Market Overview

2018 Global Healthcare Licensing - Trends: By Region (Emerging Markets) Mid-Year Review - ResearchAndMarkets.com

Share:

The "Global
Healthcare Licensing - Global Trends: By Region (Emerging Markets)
Mid-Year Review"
report has been added to ResearchAndMarkets.com's
offering.

This mid-year review report provides comprehensive analysis on all such
licensing deals and negotiations that took place between healthcare
companies of Emerging Markets during January 1, 2018 to June 30, 2018,
categorized and summarized by various important aspects such as key
countries, healthcare sub-sector, market capitalization groups, medicine
groups, licensing payment arrangements, worldwide vs domestic licensing,
and R&D vs commercialization licensing.

Such detailed analysis helps to understand the licensing trends and
directions during this time period in the healthcare segments of
Emerging Markets.

Key Features

  • 6 months' healthcare licensing transactions of Emerging Markets
    analyzed at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Licensing trends and directions summarized

Key Analysis Provided (January-June 2018)

  • Total number of licensing deals signed by companies of Emerging Markets
  • Total number of companies/institutes of Emerging Markets involved in
    the licensing deals
  • Most licensing deals signed by companies of which sub-industry within
    healthcare sector
  • Most licensing deals signed by which country's companies
  • Most licensing deals signed by which market capitalization group's
    companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
  • Number of R&D and commercialization licensing

For more information about this report visit https://www.researchandmarkets.com/research/n4mkrh/2018_global?w=4

View Comments and Join the Discussion!